Main Session
Sep 28
CT 01 - Clinical Trials

3 - 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer; Primary Endpoint Analysis of the Phase II LUNAR Randomized Trial

01:00pm - 01:10pm PT
San Francisco Ballroom

Presenter(s)

Amar Kishan, MD Headshot
Amar Kishan, MD - UCLA, Culver City, California